Clinical characteristics and outcomes of psoriasis patients with COVID-19: A retrospective, multicenter cohort study in China

CONCLUSIONS: A reduced risk of psoriasis exacerbation after SARS-CoV-2 infection was observed with biologics compared to traditional systemic and nonsystemic treatments. Significant risk factors for exacerbation after infection were identified as existing psoriatic lesions and hypertension.TRIAL REGISTRATION: ClinicalTrials.gov (No. NCT05961605).PMID:38710539 | DOI:10.1097/CM9.0000000000003024

Source: Chinese Medical Journal - May 6, 2024 Category: General Medicine Authors: Yanhua Liu Zhongrui Xu Jian Zhou Aijun Chen Junling Zhang Xiaojing Kang Xian Jiang Chengzhi Lyu Chunrui Shi Yuling Shi Xiaoming Liu Fuqiu Li Bin Yang Yongmei Huang Chen Yu Gang Wang Source Type: research